Your browser doesn't support javascript.
loading
Study on postprandial bioequivalence of Diacerein capsules in healthy volunteers / 中国药房
China Pharmacy ; (12): 2266-2270, 2022.
Artigo em Chinês | WPRIM | ID: wpr-943070
ABSTRACT
OBJECTIVE To evaluate the postprandial bioequivalence of two kinds of Diacerein capsules in healthy volunteers with oral administration . METHODS A total of 24 adult healthy subjects were included and randomly divided into two groups , with 12 subjects in each group . A randomized ,open,double-cycle cross -over trial design was adopted . Both groups took 50 mg of the test preparation (domestic Diacerein capsules )or the reference preparation (Ambridine®)respectively at 30 min after eating the standard meal in the morning of the first day of each cycle of the trial . The cleaning period was one week . Blood samples were collected at different time points before and after taking the medicine and the protein was precipitated with methanol for sample pretreatment. The concentration of active metabolite rhein was determined by LC -MS/MS using emodin as internal standard . The pharmacokinetic parameters were calculated with DAS 3.2.9 software,and the bioequivalence of test and reference preparation were evaluated. RESULTS After the subjects took the test preparation and the reference preparation after meal , the main pharmacokinetic parameters of rhein were as follows :cmax were(3 517±1 121)and(3 225±755)ng/mL;AUC0-24h were (25 764±6 134)and(24 316±5 856)ng·h/mL;AUC0-∞ were(26 679±6 409)and(25 170±6 415)ng·h/mL;tmaxwere 3.50 (0.67,12.00)and 4.00(1.50,7.00)h;t1/2 were(4.26±1.12)and(4.19±1.05)h,respectively. The 90% confidence intervals of the geometric mean ratios of cmax,AUC0-24h and AUC 0-∞ were 100.8%-113.9%,103.1%-109.4% and 103.2%-109.9%,respectively. CONCLUSIONS The test preparation and reference preparation are bioequivalent in the postprandial state of healthy subjects .

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Tipo de estudo: Ensaio Clínico Controlado Idioma: Chinês Revista: China Pharmacy Ano de publicação: 2022 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Tipo de estudo: Ensaio Clínico Controlado Idioma: Chinês Revista: China Pharmacy Ano de publicação: 2022 Tipo de documento: Artigo